戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 290作成日:2026年10月24日

2-amino-N,6-dimethoxybenzamide → 2-[[2-[(2,5-dimethylpyrazol-3-yl)amino]-5-(trifluoromethyl)pyridin-4-yl]amino]-N,6-dimethoxybenzamide

https://huagongshe.com/ja/reaction/290

反応式

関与物質

役割名称HCID仕込み量
反応物2-amino-N,6-dimethoxybenzamideHCID 56951659—
反応物N-(1,3-dimethylpyrazol-5-yl)-4-iodo-5-(trifluoromethyl)pyridin-2-amineHCID 67075489—
試薬Cesium carbonateHCID 10796—
触媒1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
触媒Palladium (II) acetateHCID 4144353—
溶媒1,4-DioxaneHCID 31275—
生成物2-[[2-[(2,5-dimethylpyrazol-3-yl)amino]-5-(trifluoromethyl)pyridin-4-yl]amino]-N,6-dimethoxybenzamideHCID 5695155071.59%

反応条件

温度90 °C

反応手順

N-(1,3-dimethyl-1H-pyrazol-5-yl)-4-iodo-5-(trifluoromethyl)pyridin-2-amine (22.8 g, 59.67 mmol), 2-amino-N,6-dimethoxybenzamide (19.90 g, 101.43 mmol), diacetoxypalladium (0.670 g, 2.98 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (3.45 g, 5.97 mmol) and cesium carbonate (23.33 g, 71.60 mmol) were suspended in 1,4-dioxane (199 ml). The reaction was degased, purged with nitrogen and heated to 90 °C => _reaction turned to dark brown and solidified after ~15 minutes._ 1,4-dioxane (50 mL) was added and reaction was stirred at 90°C (internal temperature) overnight => _stirring became easier and mixture turned to beige/yellow then to dark green/grey during the night._ Reaction was concentrated to dryness. Residue was diluted with CH2Cl2 (300 mL) and water (300 mL). Aqueous was extracted with CH2Cl2 (100 mL) then with CH2Cl2/MeOH 9/1 (100 mL) => _aqueous still contained expected product._ Aqueous was saturated with NaCl and extracted with CH2Cl2/MeOH 9/1 (100 mL). Combined organic layers were dried over MgSO4 and concentrated to dryness. The crude product (38.5g) was dissolved in CH2Cl2 (100 mL) for liquid injection but some product started to precipitate. Solid was filtered and washed twice with CH2Cl2 to afford 2-(2-(1,3-dimethyl-1H-pyrazol-5-ylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N,6-dimethoxybenzamide (5.2 g) as a white solid. The filtrate was purified by flash chromatography on silica gel eluting with 0 to 7% methanol in ethyl acetate. The solvent was evaporated to dryness to afford 2-(2-(1,3-dimethyl-1H-pyrazol-5-ylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N,6-dimethoxybenzamide (20.6 g) as a beige solid. Both batches of product (25.8 g) were combined and triturated in tBuOMe (50 mL) / CH2Cl2 (20 mL). The resulting solid was filtered, washed with tBuOMe (50 mL) to afford 2-(2-(1,3-dimethyl-1H-pyrazol-5-ylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N,6-dimethoxybenzamide (23 g) as a white solid. It was suspended in H2O (350 mL) and stirred at room temperature overnight => _mixture solidified._ It was filtered and dried over P2O5 under high vacuum for 6 hours. The resulting solid was suspended in acetonitrile (460 mL) and stirred at room temperature over the weekend. It was filtered, washed with cold acetonitrile and dried under high vacuum at 50°C overnight to afford 2-(2-(1,3-dimethyl-1H-pyrazol-5-ylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N,6-dimethoxybenzamide (8.4 g, 31.3%, EN03787-12-01) as a white solid => _product is quite soluble in acetonitrile, volume of solvent was too important (ref from PARD : 50mg in 1mL)_ Filtrate was concentrated to ~100 mL (= until preciptation occured on the rotavapor) and then stirred at room temperature for 4 hours. The resulting solid was filtered and dried under high vacuum at 50°C overnight to afford 2-(2-(1,3-dimethyl-1H-pyrazol-5-ylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N,6-dimethoxybenzamide (9.3 g, 34.6%, EN03787-12-02) as a white solid. Filtrate was concentrated to dryness to afford another batch of impure product (2.8g) which was slurried in CH3CN (28 mL) at room temperature overnight. The resulting solid was filtered and dried under high vacuum at 50°C to afford 2-(2-(1,3-dimethyl-1H-pyrazol-5-ylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N,6-dimethoxybenzamide (1.54 g, 5.73%, EN03787-12-03) as a white solid => _this batch is less pure than the 2 others_

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-a7be07888e18485384d8c572f896eab3
出典メモ750 AstraZeneca ELN dataset